Sanofi vaccine to enter Phase III of clinical trials
On 27 May 2021, the Sanofi laboratory announced the transition to large-scale trials of its Covid-19 vaccine. Phase III is used to evaluate the efficiency of the vaccine, which will be tested on 35 000 people in several countries, including the United States.
In a best-case scenario, Sanofi's vaccine could be marketed by the end of 2021, one year after the first Covid-19 vaccines became available.
Read also | Covid-19: the cost of global vaccination
0
Your rating: None
Fri, 28/05/2021 - 10:03
The online magazine
Live coverage
04/25
04/25
04/25
04/24
04/24
Latest news